![Jon Wigginton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon Wigginton
Direktor/Vorstandsmitglied bei
SUTRO BIOPHARMA, INC.
Vermögen: - $ am 30.06.2026
Profil
Jon Marc Wigginton currently serves as Independent Director at Sutro Biopharma, Inc. since 2020, Director at UbiVac, Inc. since 2020, Director at Kalivir Immunotherapeutics, Inc., and President-Research & Development at Bright Peak Therapeutics AG.
Former roles include Chairman-SAB at Cullinan Therapeutics, Inc. from 2021 to 2022, Executive Director-Discovery Medicine-Clinical at Bristol Myers Squibb Co. from 2008 to 2013, Director-Clinical Oncology at Merck Research Laboratories Massachusetts LLC from 2006 to 2008, Independent Director at Checkmate Pharmaceuticals, Inc. in 2022, Chief Medical Officer & SVP-Clinical Development at MacroGenics, Inc. from 2016 to 2020, Head-Investigational Biologics Section at Center for Cancer Research from 1992 to 2007, Chief Medical Officer at Cullinan Oncology LLC, and President at Society For Immunotherapy of Cancer.
Education includes undergraduate and doctorate degrees from the University of Michigan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Jon Wigginton
| Unternehmen | Position | Beginn |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 30.11.2020 |
UbiVac, Inc.
 UbiVac, Inc. BiotechnologyHealth Technology Engages in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases | Direktor/Vorstandsmitglied | 15.10.2020 |
Kalivir Immunotherapeutics, Inc.
 Kalivir Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Jon Wigginton
| Unternehmen | Position | Ende |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2022 |
| CHECKMATE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 31.05.2022 |
| MACROGENICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.03.2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
Ausbildung von Jon Wigginton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
UbiVac, Inc.
UbiVac, Inc. BiotechnologyHealth Technology Engages in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases | Health Technology |
Center for Cancer Research
 Center for Cancer Research General GovernmentGovernment Provides current research information for patients, physicians, and scientists | Government |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Society For Immunotherapy of Cancer
 Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Commercial Services |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Kalivir Immunotherapeutics, Inc.
Kalivir Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
